• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱尿路上皮癌中 SLC14A1(UT-B)基因重排:一例报告。

SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case report.

机构信息

Department of Pathology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300, China.

Department of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300, China.

出版信息

Diagn Pathol. 2020 Jul 23;15(1):94. doi: 10.1186/s13000-020-01009-8.

DOI:10.1186/s13000-020-01009-8
PMID:32703295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7376696/
Abstract

BACKGROUND

Bladder cancer (BC) is a common and deadly disease. Over the past decade, a number of genetic alterations have been reported in BC. Bladder urothelium expresses abundant urea transporter UT-B encoded by Slc14a1 gene at 18q12.3 locus, which plays an important role in preventing high concentrated urea-caused cell injury. Early genome-wide association studies (GWAS) showed that UT-B gene mutations are genetically linked to the urothelial bladder carcinoma (UBC). In this study, we examined whether Slc14a1 gene has been changed in UBC, which has never been reported.

CASE PRESENTATION

A 59-year-old male was admitted to a hospital with the complaint of gross hematuria for 6 days. Ultrasonography revealed a size of 2.8 × 1.7 cm mass lesion located on the rear wall and dome of the bladder. In cystoscopic examination, papillary tumoral lesions 3.0-cm in total diameter were seen on the left wall of the bladder and 2 cm to the left ureteric orifice. Transurethral resection of bladder tumor (TURBT) was performed. Histology showed high-grade non-muscle invasive UBC. Immunostaining was negative for Syn, CK7, CK20, Villin, and positive for HER2, BRCA1, GATA3. Using a fluorescence in situ hybridization (FISH), Slc14a1 gene rearrangement was identified by a pair of break-apart DNA probes.

CONCLUSIONS

We for the first time report a patient diagnosed with urothelial carcinoma accompanied with split Slc14a1 gene abnormality, a crucial gene in bladder.

摘要

背景

膀胱癌(BC)是一种常见且致命的疾病。在过去的十年中,已经报道了许多 BC 的基因改变。膀胱尿路上皮在 18q12.3 位点表达大量由 Slc14a1 基因编码的尿素转运体 UT-B,该基因在防止高浓度尿素引起的细胞损伤中起重要作用。早期全基因组关联研究(GWAS)表明,UT-B 基因突变与尿路上皮膀胱癌(UBC)在遗传上有关。在这项研究中,我们检查了 Slc14a1 基因是否在 UBC 中发生了改变,这是以前从未报道过的。

病例介绍

一名 59 岁男性因血尿 6 天就诊。超声检查显示膀胱后壁和穹窿处有一个 2.8×1.7cm 的肿块。在膀胱镜检查中,可见左侧壁有 3.0cm 总直径的乳头状肿瘤病变和左侧输尿管口 2cm 处有肿瘤病变。行经尿道膀胱肿瘤切除术(TURBT)。组织学显示高级别非肌肉浸润性 UBC。免疫组化Syn、CK7、CK20、Villin 均为阴性,HER2、BRCA1、GATA3 均为阳性。采用荧光原位杂交(FISH),用一对断裂 DNA 探针鉴定 Slc14a1 基因重排。

结论

我们首次报道了一例诊断为伴有 Slc14a1 基因异常的尿路上皮癌的患者,Slc14a1 基因是膀胱中的关键基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f2/7376696/444700f4aa33/13000_2020_1009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f2/7376696/264a6fd54700/13000_2020_1009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f2/7376696/444700f4aa33/13000_2020_1009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f2/7376696/264a6fd54700/13000_2020_1009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f2/7376696/444700f4aa33/13000_2020_1009_Fig2_HTML.jpg

相似文献

1
SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case report.膀胱尿路上皮癌中 SLC14A1(UT-B)基因重排:一例报告。
Diagn Pathol. 2020 Jul 23;15(1):94. doi: 10.1186/s13000-020-01009-8.
2
SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.SLC14A1 可防止致癌代谢物积累,并募集组蛋白去乙酰化酶 1 以反式抑制尿路上皮癌中的致癌代谢物基因。
Theranostics. 2020 Sep 23;10(25):11775-11793. doi: 10.7150/thno.51655. eCollection 2020.
3
Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.多色荧光原位杂交(UroVysion)在扁平尿路上皮病变鉴别诊断中的价值
J Clin Pathol. 2008 Mar;61(3):272-7. doi: 10.1136/jcp.2007.049684. Epub 2007 Aug 10.
4
Urothelial dysplasia of the bladder: diagnostic features and clinical significance.膀胱尿路上皮发育异常:诊断特征及临床意义
Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):121-9.
5
DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.一名多灶性膀胱尿路上皮癌患者的DNA拷贝数改变和PPARG扩增
BMC Res Notes. 2012 Oct 31;5:607. doi: 10.1186/1756-0500-5-607.
6
Genetic and molecular markers of urothelial premalignancy and malignancy.尿路上皮癌前病变和恶性病变的遗传及分子标志物。
Scand J Urol Nephrol Suppl. 2000(205):82-93. doi: 10.1080/003655900750169338.
7
Amyloidosis of the bladder and association with urothelial carcinoma: report of 29 cases.膀胱淀粉样变性与尿路上皮癌的相关性:29 例报告。
Hum Pathol. 2019 Nov;93:48-53. doi: 10.1016/j.humpath.2019.08.011. Epub 2019 Aug 16.
8
Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.膀胱尿路上皮癌中UT-B表达降低的临床意义
Pathol Res Pract. 2014 Dec;210(12):799-803. doi: 10.1016/j.prp.2014.09.012. Epub 2014 Oct 7.
9
Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.以卵黄囊型成分为主的膀胱尿路上皮癌。
Int J Surg Pathol. 2022 Apr;30(2):207-213. doi: 10.1177/10668969211030688. Epub 2021 Jul 13.
10
Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.人类膀胱尿路上皮癌连续时刻的染色体不平衡。
Urol Oncol. 2013 Aug;31(6):827-35. doi: 10.1016/j.urolonc.2011.05.015. Epub 2011 Jul 16.

本文引用的文献

1
Urothelial cancer in 2017: Changes in expectations for metastatic urothelial carcinoma.2017年尿路上皮癌:转移性尿路上皮癌的预期变化
Nat Rev Clin Oncol. 2018 Feb;15(2):73-74. doi: 10.1038/nrclinonc.2017.184. Epub 2017 Dec 5.
2
Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.人尿路上皮癌中一种新型UT-B尿素转运体的鉴定
Front Physiol. 2017 Apr 28;8:245. doi: 10.3389/fphys.2017.00245. eCollection 2017.
3
Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
脊髓损伤患者膀胱癌的临床特征:来自单一中心的经验
Int Urol Nephrol. 2017 Jun;49(6):983-994. doi: 10.1007/s11255-017-1570-6. Epub 2017 Mar 22.
4
Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.肺癌中 ALK、ROS1 和 RET 重排的多重转录组分析。
Sci Rep. 2017 Feb 9;7:42259. doi: 10.1038/srep42259.
5
Emerging Bladder Cancer Biomarkers and Targets of Therapy.新兴的膀胱癌生物标志物与治疗靶点
Urol Clin North Am. 2016 Feb;43(1):63-76. doi: 10.1016/j.ucl.2015.08.006.
6
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
7
Biomarkers for bladder cancer management: present and future.膀胱癌管理的生物标志物:现状与未来。
Am J Clin Exp Urol. 2014 Apr 5;2(1):1-14. eCollection 2014.
8
Expression and localization of a UT-B urea transporter in the human bladder.人膀胱中 UT-B 尿素转运体的表达和定位。
Am J Physiol Renal Physiol. 2014 Nov 1;307(9):F1088-94. doi: 10.1152/ajprenal.00284.2014. Epub 2014 Sep 10.
9
Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder urothelium.尿素转运蛋白UT-B缺失诱导小鼠膀胱尿路上皮细胞DNA损伤和凋亡。
PLoS One. 2013 Oct 21;8(10):e76952. doi: 10.1371/journal.pone.0076952. eCollection 2013.
10
Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1.尿比重差异作为尿路上皮癌易感基因 SLC14A1 分子表型标志物的研究
Int J Cancer. 2013 Dec 15;133(12):3008-13. doi: 10.1002/ijc.28325. Epub 2013 Jul 16.